Asset Management
Build Your Comparison
Side-by-side financial analysisStock Comparison
BRBI vs LAZ vs EVR vs PJT vs HLI vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Capital Markets
Financial - Capital Markets
Financial - Capital Markets
Financial - Capital Markets
Banks - Diversified
BRBI vs LAZ vs EVR vs PJT vs HLI vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||||
|---|---|---|---|---|---|---|
| Industry | Asset Management | Financial - Capital Markets | Financial - Capital Markets | Financial - Capital Markets | Financial - Capital Markets | Banks - Diversified |
| Market Cap | $913M | $4.30B | $13.47B | $3.80B | $9.57B | $869.15B |
| Revenue (TTM) | $7.41B | $3.16B | $3.88B | $1.81B | $2.65B | $280.33B |
| Net Income (TTM) | $194M | $237M | $592M | $187M | $448M | $57.05B |
| Gross Margin | 5.9% | 31.2% | 99.4% | 32.7% | 37.3% | 60.0% |
| Operating Margin | 3.2% | 11.1% | 20.5% | 21.3% | 21.1% | 25.9% |
| Forward P/E | 24.4x | 16.4x | 17.7x | 20.9x | 17.8x | 14.0x |
| Total Debt | $9.93B | $2.58B | $1.16B | $414M | $438M | $942.38B |
| Cash & Equiv. | $575M | $1.50B | $1.47B | $539M | $971M | $343.34B |
BRBI vs LAZ vs EVR vs PJT vs HLI vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| BRBI BR Partners S.… (BRBI) | 100 | 11600000.0 | +11599900.0% |
| Lazard Ltd (LAZ) | 100 | 159.8 | +59.8% |
| Evercore Inc. (EVR) | 100 | 577.3 | +477.3% |
| PJT Partners Inc. (PJT) | 100 | 306.4 | +206.4% |
| Houlihan Lokey, Inc. (HLI) | 100 | 246.4 | +146.4% |
| JPMorgan Chase & Co. (JPM) | 100 | 330.8 | +230.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BRBI vs LAZ vs EVR vs PJT vs HLI vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BRBI has the current edge in this matchup, primarily because of its strength in quality and efficiency.
- Efficiency ratio 0.0% vs EVR's 0.8% (lower = leaner)
- Efficiency ratio 0.0% vs EVR's 0.8%
LAZ ranks third and is worth considering specifically for defensive.
- Beta 1.73, yield 3.8%, current ratio 29.35x
- 3.8% yield, vs EVR's 1.0%, (1 stock pays no dividend)
EVR is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.
- Rev growth 29.5%, EPS growth 54.7%
- 6.1% 10Y total return vs PJT's 5.2%
- 29.5% NII/revenue growth vs LAZ's 3.2%
- +38.7% vs HLI's -20.7%
PJT doesn't hold a clear category lead here; it's more of a secondary option in this specific comparison.
HLI is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.85, Low D/E 20.1%, current ratio 1.38x
- Beta 0.85 vs EVR's 1.81, lower leverage
JPM is the clearest fit if your priority is income & stability and valuation efficiency.
- Dividend streak 15 yrs, beta 0.95, yield 1.9%
- PEG 1.07 vs PJT's 2.40
- NIM 2.2% vs PJT's 1.7%
- Lower P/E (14.0x vs 17.8x), PEG 1.07 vs 1.13
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 29.5% NII/revenue growth vs LAZ's 3.2% | |
| Value | Lower P/E (14.0x vs 17.8x), PEG 1.07 vs 1.13 | |
| Quality / Margins | Efficiency ratio 0.0% vs EVR's 0.8% (lower = leaner) | |
| Stability / Safety | Beta 0.85 vs EVR's 1.81, lower leverage | |
| Dividends | 3.8% yield, vs EVR's 1.0%, (1 stock pays no dividend) | |
| Momentum (1Y) | +38.7% vs HLI's -20.7% | |
| Efficiency (ROA) | Efficiency ratio 0.0% vs EVR's 0.8% |
BRBI vs LAZ vs EVR vs PJT vs HLI vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
BRBI vs LAZ vs EVR vs PJT vs HLI vs JPM — Financial Metrics
Side-by-side numbers across 6 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
JPM leads in 2 of 6 categories
PJT leads 1 • EVR leads 1 • BRBI leads 0 • LAZ leads 0 • HLI leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
JPM leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 155.1x PJT's $1.8B. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to BRBI's 2.6%.
| Metric | ||||||
|---|---|---|---|---|---|---|
| RevenueTrailing 12 months | $7.4B | $3.2B | $3.9B | $1.8B | $2.6B | $280.3B |
| EBITDAEarnings before interest/tax | — | $384M | $804M | $412M | $609M | $81.4B |
| Net IncomeAfter-tax profit | — | $237M | $592M | $187M | $448M | $57.0B |
| Free Cash FlowCash after capex | — | $519M | $1.2B | $614M | $739M | $100.9B |
| Gross MarginGross profit ÷ Revenue | +5.9% | +31.2% | +99.4% | +32.7% | +37.3% | +60.0% |
| Operating MarginEBIT ÷ Revenue | +3.2% | +11.1% | +20.5% | +21.3% | +21.1% | +25.9% |
| Net MarginNet income ÷ Revenue | +2.6% | +7.5% | +15.3% | +10.3% | +16.9% | +20.4% |
| FCF MarginFCF ÷ Revenue | +1.2% | +16.4% | +30.5% | +34.0% | +27.9% | +36.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | — | -43.8% | +44.2% | +11.1% | +22.3% | +16.0% |
Valuation Metrics
JPM leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 15.5x trailing earnings, JPM trades at a 36% valuation discount to BRBI's 24.4x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 1.19x vs PJT's 2.70x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||||
|---|---|---|---|---|---|---|
| Market CapShares × price | $913M | $4.3B | $13.5B | $3.8B | $9.6B | $869.1B |
| Enterprise ValueMkt cap + debt − cash | $2.7B | $5.4B | $13.2B | $3.7B | $9.0B | $1.47T |
| Trailing P/EPrice ÷ TTM EPS | 24.43x | 21.08x | 24.21x | 23.55x | 23.56x | 15.52x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 16.38x | 17.70x | 20.90x | 17.80x | 13.97x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 2.14x | 2.70x | 1.49x | 1.19x |
| EV / EBITDAEnterprise value multiple | 57.04x | 11.95x | 16.36x | 9.33x | 16.64x | 18.03x |
| Price / SalesMarket cap ÷ Revenue | 0.64x | 1.35x | 3.47x | 2.22x | 4.00x | 3.11x |
| Price / BookPrice ÷ Book value/share | 5.88x | 4.92x | 6.51x | 4.46x | 4.33x | 2.40x |
| Price / FCFMarket cap ÷ FCF | 54.18x | 8.50x | 11.39x | 7.91x | 11.83x | 8.62x |
Profitability & Efficiency
PJT leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
EVR delivers a 29.3% return on equity — every $100 of shareholder capital generates $29 in annual profit, vs $16 for JPM. HLI carries lower financial leverage with a 0.20x debt-to-equity ratio, signaling a more conservative balance sheet compared to BRBI's 12.34x. On the Piotroski fundamental quality scale (0–9), PJT scores 7/9 vs JPM's 5/9, reflecting strong financial health.
| Metric | ||||||
|---|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +23.8% | +26.7% | +29.3% | +20.1% | +20.1% | +15.9% |
| ROA (TTM)Return on assets | +1.5% | +5.2% | +14.1% | +11.1% | +11.9% | +1.3% |
| ROICReturn on invested capital | +2.0% | +9.5% | +18.8% | +20.3% | +15.5% | +4.5% |
| ROCEReturn on capital employed | +2.3% | +9.5% | +17.6% | +21.2% | +20.1% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 6 | 7 | 7 | 5 |
| Debt / EquityFinancial leverage | 12.34x | 2.61x | 0.50x | 0.41x | 0.20x | 2.60x |
| Net DebtTotal debt minus cash | $9.4B | $1.1B | -$311M | -$125M | -$533M | $599.0B |
| Cash & Equiv.Liquid assets | $575M | $1.5B | $1.5B | $539M | $971M | $343.3B |
| Total DebtShort + long-term debt | $9.9B | $2.6B | $1.2B | $414M | $438M | $942.4B |
| Interest CoverageEBIT ÷ Interest expense | — | 4.74x | 32.72x | — | — | 0.74x |
Total Returns (Dividends Reinvested)
EVR leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in EVR five years ago would be worth $25,068 today (with dividends reinvested), compared to $11,784 for LAZ. Over the past 12 months, EVR leads with a +38.7% total return vs HLI's -20.7%. The 3-year compound annual growth rate (CAGR) favors EVR at 43.0% vs HLI's 16.4% — a key indicator of consistent wealth creation.
| Metric | ||||||
|---|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -15.5% | -6.0% | -2.7% | -6.9% | -21.5% | -3.5% |
| 1-Year ReturnPast 12 months | — | +8.6% | +38.7% | +2.0% | -20.7% | +18.8% |
| 3-Year ReturnCumulative with dividends | — | +68.9% | +192.3% | +124.2% | +57.9% | +131.9% |
| 5-Year ReturnCumulative with dividends | — | +17.8% | +150.7% | +138.9% | +94.2% | +102.6% |
| 10-Year ReturnCumulative with dividends | +41470.8% | +95.7% | +605.6% | +523.2% | +534.0% | +433.9% |
| CAGR (3Y)Annualised 3-year return | — | +19.1% | +43.0% | +30.9% | +16.4% | +32.4% |
Risk & Volatility
Evenly matched — HLI and JPM each lead in 1 of 2 comparable metrics.
Risk & Volatility
HLI is the less volatile stock with a 0.85 beta — it tends to amplify market swings less than EVR's 1.81 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JPM currently trades 92.2% from its 52-week high vs BRBI's 17.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||||
|---|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.02x | 1.73x | 1.81x | 1.04x | 0.85x | 0.95x |
| 52-Week HighHighest price in past year | $67.01 | $58.75 | $388.71 | $195.62 | $211.78 | $337.25 |
| 52-Week LowLowest price in past year | $0.00 | $38.67 | $238.96 | $127.73 | $134.41 | $262.71 |
| % of 52W HighCurrent price vs 52-week peak | +17.3% | +77.9% | +87.5% | +80.4% | +64.7% | +92.2% |
| RSI (14)Momentum oscillator 0–100 | 33.6 | 47.2 | 50.3 | 54.1 | 34.6 | 59.6 |
| Avg Volume (50D)Average daily shares traded | 2K | 1.2M | 475K | 320K | 597K | 7.1M |
Analyst Outlook
Evenly matched — LAZ and EVR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: LAZ as "Buy", EVR as "Buy", PJT as "Hold", HLI as "Buy", JPM as "Buy". Consensus price targets imply 37.1% upside for HLI (target: $188) vs 0.9% for PJT (target: $159). For income investors, LAZ offers the higher dividend yield at 3.84% vs PJT's 0.54%.
| Metric | ||||||
|---|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | — | $48.50 | $382.67 | $158.67 | $188.00 | $338.78 |
| # AnalystsCovering analysts | — | 29 | 21 | 12 | 15 | 61 |
| Dividend YieldAnnual dividend ÷ price | — | +3.8% | +1.0% | +0.5% | +1.8% | +1.9% |
| Dividend StreakConsecutive years of raises | 1 | 0 | 19 | 0 | 11 | 15 |
| Dividend / ShareAnnual DPS | — | $1.75 | $3.25 | $0.86 | $2.41 | $5.95 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.1% | +4.9% | +5.1% | +0.5% | +4.0% |
JPM leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). PJT leads in 1 (Profitability & Efficiency). 2 tied.
BRBI vs LAZ vs EVR vs PJT vs HLI vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BRBI or LAZ or EVR or PJT or HLI or JPM a better buy right now?
For growth investors, Evercore Inc.
(EVR) is the stronger pick with 29. 5% revenue growth year-over-year, versus 3. 2% for Lazard Ltd (LAZ). JPMorgan Chase & Co. (JPM) offers the better valuation at 15. 5x trailing P/E (14. 0x forward), making it the more compelling value choice. Analysts rate Lazard Ltd (LAZ) a "Buy" — based on 29 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BRBI or LAZ or EVR or PJT or HLI or JPM?
On trailing P/E, JPMorgan Chase & Co.
(JPM) is the cheapest at 15. 5x versus BRBI BR Partners S. A. ADSs at 24. 4x. On forward P/E, JPMorgan Chase & Co. is actually cheaper at 14. 0x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 1. 07x versus PJT Partners Inc. 's 2. 40x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — BRBI or LAZ or EVR or PJT or HLI or JPM?
Over the past 5 years, Evercore Inc.
(EVR) delivered a total return of +150. 7%, compared to +17. 8% for Lazard Ltd (LAZ). Over 10 years, the gap is even starker: BRBI returned +414. 7% versus LAZ's +95. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BRBI or LAZ or EVR or PJT or HLI or JPM?
By beta (market sensitivity over 5 years), Houlihan Lokey, Inc.
(HLI) is the lower-risk stock at 0. 85β versus Evercore Inc. 's 1. 81β — meaning EVR is approximately 113% more volatile than HLI relative to the S&P 500. On balance sheet safety, Houlihan Lokey, Inc. (HLI) carries a lower debt/equity ratio of 20% versus 12% for BRBI BR Partners S. A. ADSs — giving it more financial flexibility in a downturn.
05Which is growing faster — BRBI or LAZ or EVR or PJT or HLI or JPM?
By revenue growth (latest reported year), Evercore Inc.
(EVR) is pulling ahead at 29. 5% versus 3. 2% for Lazard Ltd (LAZ). On earnings-per-share growth, the picture is similar: Evercore Inc. grew EPS 54. 7% year-over-year, compared to -19. 0% for Lazard Ltd. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BRBI or LAZ or EVR or PJT or HLI or JPM?
JPMorgan Chase & Co.
(JPM) is the more profitable company, earning 20. 4% net margin versus 2. 6% for BRBI BR Partners S. A. ADSs — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus 3. 2% for BRBI. At the gross margin level — before operating expenses — EVR leads at 99. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BRBI or LAZ or EVR or PJT or HLI or JPM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 1. 07x versus PJT Partners Inc. 's 2. 40x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, JPMorgan Chase & Co. (JPM) trades at 14. 0x forward P/E versus 20. 9x for PJT Partners Inc. — 6. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HLI: 37. 1% to $188. 00.
08Which pays a better dividend — BRBI or LAZ or EVR or PJT or HLI or JPM?
In this comparison, LAZ (3.
8% yield), JPM (1. 9% yield), HLI (1. 8% yield), EVR (1. 0% yield), PJT (0. 5% yield) pay a dividend. BRBI does not pay a meaningful dividend and should not be held primarily for income.
09Is BRBI or LAZ or EVR or PJT or HLI or JPM better for a retirement portfolio?
For long-horizon retirement investors, Houlihan Lokey, Inc.
(HLI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 85), 1. 8% yield, +534. 0% 10Y return). Lazard Ltd (LAZ) carries a higher beta of 1. 73 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HLI: +534. 0%, LAZ: +95. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BRBI and LAZ and EVR and PJT and HLI and JPM?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: BRBI is a small-cap quality compounder stock; LAZ is a small-cap income-oriented stock; EVR is a mid-cap high-growth stock; PJT is a small-cap quality compounder stock; HLI is a small-cap high-growth stock; JPM is a large-cap deep-value stock. LAZ, EVR, PJT, HLI, JPM pay a dividend while BRBI does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.